Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00031304 · ClinicalTrials.gov registry record
Screening Protocol for HIV Vaccine Studies
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,324
- Enrollment target
NCT00031304 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,324 participants.
The verdict
NCT00031304 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,324 participants
- Enrollment target
Study Summary
Healthy volunteers will be screened under this protocol for possible participation in a study testing a vaccine against HIV, the virus that causes AIDS. Healthy adults 18 to 60 years of age may be eligible for this study. Participants must be in good general health with no history of significant medical problems or abnormal laboratory test results. Pregnant or breast-feeding women and people infected with HIV will not be enrolled. Participants enrolled in this protocol will undergo the following tests and procedures within 8 weeks before the start of the experimental vaccine study: * Medical history, including history of sexual activity and drug use * Physical examination * Pregnancy test for women of childbearing age * Blood and urine tests to evaluate possible medical problems such as liver and kidney function; to evaluate immune function; and to test for HIV, hepatitis and syphilis Individuals who are identified through this screening protocol as possible candidates for an HIV vaccine trial will be provided additional information about study options.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,324 participants |
| Start Date | 2002-02-27 |
| Est. Completion | 2013-04-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00031304
The ClinicalTrials.gov registry entry for NCT00031304 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,324 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00031304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00031304 about?
NCT00031304 is a clinical study titled "Screening Protocol for HIV Vaccine Studies". Healthy volunteers will be screened under this protocol for possible participation in a study testing a vaccine against HIV, the virus that causes AIDS. Healthy adults 18 to 60 years of age may be eligible for this study. Participants must be in good general health with no history of significant me...
What is the current status of trial NCT00031304?
This trial is currently completed. The enrollment target is 1,324 participants. The study started on 2002-02-27. Estimated completion is 2013-04-08.
Who is sponsoring clinical trial NCT00031304?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.